Channels - Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab :: FRELIP Discovery

Similar Items: Personalized Biologic Therapy for Refractory Bullous Pemphigoid: Sequential Omalizumab, Dupilumab, and Rituximab

Quick Look
Bullous Pemphigoid Possibly Induced by Deucravacitinib in a Patient with Psoriasis
Quick Look
Secondary Syphilis With Concomitant Bullous Pemphigoid: A Case Report
Quick Look
Mendelian Randomization and Experimental Validation Identify Key Immune Signatures in Bullous Pemphigoid
Quick Look
Successful Treatment of Refractory Lichen Amyloidosus With Dupilumab
Quick Look
Successful Treatment of Refractory Chronic Spontaneous Urticaria with Stapokibart After Omalizumab Failure: A Case Report
Quick Look
Analysis of Predictors of Response Degree to Omalizumab in 124 Patients with Chronic Spontaneous Urticaria
Quick Look
Mucous membrane pemphigoid of the larynx: A rare threat to vocal and airway integrity
Quick Look
Efficacy and Safety of Rituximab in Pemphigus Foliaceus: A Systematic Review and Meta-analysis
Quick Look
Autoimmunity to Collagen XVII (BP180-Ag2) in Pemphigoid Associated With Parkinson’s Disease
Quick Look
Nemolizumab Versus Dupilumab in the Treatment of Prurigo Nodularis: Systematic Literature Review and Network Meta-analysis
Quick Look
A Rapidly Evolving Vesiculobullous Eruption in a Toddler: A Case of Linear IgA Bullous Dermatosis
Quick Look
Dupilumab Can Be Effective for Immune-Related Adverse Event Dermatitis: A Case Report and Review of the Literature
Quick Look
A Durability Index for Atopic Dermatitis: Indirect Comparison of Lebrikizumab, Dupilumab, and Tralokinumab in Maintaining Efficacy Under Variable Treatment Adherence
Quick Look
Successful Treatment of Extensive Ritlecitinib-Refractory Alopecia Areata with Upadacitinib
Quick Look
Chronic refractory cutaneous sarcoidosis successfully treated with oral tofacitinib
Quick Look
Characteristics of Dupilumab-Treated Patients with Atopic Dermatitis Over Time: A Cross-Sectional Assessment of Potential Channeling Bias upon Pediatric Label Extension
Quick Look
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
Quick Look
Immunosenescence in Older Patients with Psoriasis: Mechanistic Insights and Opportunities for Biologic Therapy
Quick Look
Successful Treatment of IL‐23 Inhibitor–Refractory Nail Psoriasis With Deucravacitinib: A Case Report
Quick Look
Microneedling Combined with Photothermal-Biomodulated Autologous PRP to Enhance Exosome Release in Refractory Melasma: A Case Report
Quick Look
Achieving Steroid-Sparing Remission in Refractory Pyoderma Gangrenosum With an Integrative Meta-Therapeutic System Based on Traditionally Engineered Nanomercury Sulfide: A Case Series
Quick Look
Refractory Periungual Warts Treated with Filiform Fire Needle Combined with Warming-Yang and Collateral-Dredging Chinese Medicine Soak: A Two-Case Report
Quick Look
The use of collagen IV immunohistochemistry in the diagnosis of bullous pemphigoid
Quick Look
Personalized Medicine in Psoriasis – A Long Road Ahead?